QbD Year event 2023
The QbD Group has been actively supporting our research into glioblastoma after Pieter Van Vlierberghe was diagnosed with glioblastoma in 2020 (a close friend of QbD’s CEO Bart Van Acker).
Pieter, unfortunately, succumbed to the disease at the end of 2022 after a courageous battle. However, QbD remains dedicated to continuing the research in honour of Pieter and helping future patients facing this devastating disease.
In 2021 an Endowed chair was created by QbD. Thanks to this support our group and a group from Ghent University were able to join forces to perform Precision Oncology Research on Glioblastoma.
On June 8th, QbD held its yearly research update event at the beautiful location of Salons van Edel.
It was an entertaining evening with interesting guest speakers. Dirk Reyn presented his book “Biotech in Vlaanderen”, followed by a talk by Jeroen Baert in which the advantages and pitfalls of AI were discussed, with a great sense of humour. After this, it was time for more serious work and an update was given on the research work on glioblastoma by researchers Frederik De Smet, Yanti De Visser and Winnok De Vos.